Kennedy disease Advocacy Hub | UniteRare

At a Glance

Live from database

Regulatory Watchboard

10 events

May 2026Clinical Trial to Test Efficacy of Targeting Hypoxia Combined With ARSI After First-line ARSI Therapy for Castrate Resistant Prostate Cancer

University Health Network, Toronto — PHASE2

TrialNOT YET RECRUITING

Apr 2026High Cardiovascular Risk Intervention With Cardio-Oncology Consultation for Prostate Cancer Following Androgen Receptor Pathway Inhibitor (ARPI) Therapy (Heart-Safe)

Cedars-Sinai Medical Center — PHASE2

TrialNOT YET RECRUITING

Mar 2026Novel ACK1 Inhibitor (R)-9b in Patients With Prostate Cancer

TechnoGenesys, Inc. — PHASE1

TrialRECRUITING

Mar 2026Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins — PHASE2

TrialRECRUITING

Mar 2026Pacritinib in Participants With Metastatic Castrate-Resistant Prostate Cancer That Progressed on or After Prior Treatment With Androgen Receptor Signaling Inhibitors

Medical College of Wisconsin — PHASE2

TrialNOT YET RECRUITING

Feb 2026A Phase III Study Comparing HRS-4357 With Novel Androgen Receptor Pathway Inhibitors in Patients With Progressive, PSMA-Positive Metastatic Castration-Resistant Prostate Cancer

Jiangsu HengRui Medicine Co., Ltd. — PHASE3

TrialRECRUITING

Dec 2025A Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA-positive mCRPC

Novartis Pharmaceuticals — PHASE1, PHASE2

TrialRECRUITING

Nov 2025An Observational Study to Learn More About How Medicines That Block Male Hormones Are Used in People With Prostate Cancer in Australia

Bayer

TrialNOT YET RECRUITING

Oct 2025Quality of Life, Functional and Cognitive Outcomes in Patients With Metastatic Hormone-Sensitive Prostate Cancer

Ankara Etlik City Hospital

TrialRECRUITING

Oct 2025Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer

Amgen — PHASE1

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

Total programs

No financial assistance programs currently listed for Kennedy disease.
Check the disease page for updates →

Clinical Trial Landscape

6 active trials

1Phase 2

2N/A

2Unknown

1PHASE2, PHASE3

6Total recruiting

Search clinical trials for Kennedy disease →

Recent News & Research

No recent news articles indexed yet for Kennedy disease.
Search PubMed for Kennedy disease →

Browse all Kennedy disease news →

Specialist Network

Top 6 by expertise

Manoj Pandey, Ms, PhD

Banaras Hindu University

Score 302 trials

Toni K Choueiri, MD, M.D

Dana-Farber Cancer Institute

📍 BOSTON, MA

Score 295 trials

Daniel George, MD

Duke University

Score 264 trials

Ajay Gopal

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

📍 SEATTLE, WA

Score 1814 trials

Gianni Sorarù, MD

Azienda Ospedale Università di Padova

📍 Padua, PD

Score 91 trial1 pub

Chiara Marini-Bettolo, MD, PhD

Newcastle University

📍 Newcastle upon Tyne

Score 83 trials

View all Kennedy disease specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰